Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14781
-
14782
Chronic Exposure to Perfluorooctane Sulfonate Induces Behavior Defects and Neurotoxicity through Oxidative Damages, <i>In Vivo</i> and <i>In Vitro</i>
Published 2014“…Using green fluorescent protein (GFP) labelled transgenic strains, we found that PFOS caused down-regulated expression of a chemoreceptor gene, <i>gcy-5</i>, in ASE chemosensory neurons, but did not affect cholinergic neurons and dopaminergic neurons. …”
-
14783
Improving Degradation Efficiency of Organic Pollutants through a Self-Powered Alternating Current Electrocoagulation System
Published 2021“…Moreover, the removal efficiency can be further enhanced by decreasing the frequency AC, in which a 5.7-fold improvement was achieved at 0.2 Hz compared to DC at 1.8 Hz. …”
-
14784
Improving Degradation Efficiency of Organic Pollutants through a Self-Powered Alternating Current Electrocoagulation System
Published 2021“…Moreover, the removal efficiency can be further enhanced by decreasing the frequency AC, in which a 5.7-fold improvement was achieved at 0.2 Hz compared to DC at 1.8 Hz. …”
-
14785
Supplementary Material for: Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy
Published 2015“…First-line treatments were endothelin receptor antagonists in 11 patients, phosphodiesterase-5 inhibitors in 11 patients, calcium blocker in 1 patient, combination therapy in 3 patients including 2 with a prostanoid. …”
-
14786
Percent changes (Δ-values are differences between means) in protein levels and proteolytic activity of Separase after IM treatment when compared to corresponding untreated cells.
Published 2015“…Example (K526): (100+9.1)/(100–56.9) = 2.5</p><p>Abbreviations: d, days; h, hours; IM, imatinib; +, increase;-, decrease.…”
-
14787
-
14788
-
14789
-
14790
-
14791
-
14792
<i>Rpl5</i> mutant ES cells exhibit a p53-independent G2 cell cycle arrest.
Published 2014“…In contrast, the cell cycle profile of the <i>Rpl5</i> mutant ES cells exhibited a three-fold increase in the G2 phase with a concomitant decrease in the G1 and S phases, consistent with a delayed G2 phase transition (A, C) (three independent pooled experiments). …”
-
14793
-
14794
-
14795
Integrins αvβ3 and αvβ5 are human endothelial cell receptors for serum-coated <i>C</i>. <i>glabrata</i>.
Published 2022“…(G and H) Inhibition of gC1qR (with monoclonal antibody 74.5.2) and αv integrins has an additive effect on decreasing the endocytosis (G) but not cell-association of serum-coated <i>C</i>. …”
-
14796
Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A<sub>2A</sub> and dopamine D<sub>2</sub> receptors for Parkinson's disease treatment - Fig 5
Published 2018“…<p>Dose-response curves of compound <b>5</b> (A), compound <b>6</b> (B) and (±)-PPHT.HCl (C) in D<sub>2</sub>R-proteopolymersomes-based fluorescence polarisation (FP) competition assay with BODIPY-NAPS. …”
-
14797
Table1_Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis.xlsx
Published 2022“…<p>The Chanarin–Dorfman syndrome (CDS) is a rare, autosomal recessively inherited genetic disease, whch is associated with a decrease in the lipolysis activity in multiple tissue cells. …”
-
14798
-
14799
-
14800